OraSure Technologies, Inc. provides point-of-care and home diagnostic tests, sample management solutions, and microbiome laboratory and analytical services. The Company's product portfolio is divided into diagnostics products and sample management solutions. Its business consists of the development, manufacture, marketing and sale of diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products including immunoassays and other in vitro diagnostic tests that are used on other specimen types. Its diagnostic products include tests for diseases including COVID-19, HIV and Hepatitis C that are performed on a rapid basis at the point of care, and tests for drugs of abuse that are processed in a laboratory. Its business also includes molecular sample management solutions and services that are used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.
종목 코드 OSUR
회사 이름OraSure Technologies Inc
상장일Nov 17, 1986
CEOMs. Carrie Eglinton Manner
직원 수501
유형Ordinary Share
회계 연도 종료Nov 17
주소220 E First St
도시BETHLEHEM
증권 거래소NASDAQ Global Select Consolidated
국가United States of America
우편 번호18015
전화15036416115
웹사이트https://www.orasure.com/
종목 코드 OSUR
상장일Nov 17, 1986
CEOMs. Carrie Eglinton Manner
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음